A randomized crossover trial to assess therapeutic efficacy and cost reduction of acid ursodeoxycholic manufactured by the university hospital for the treatment of primary biliary cholangitis.

Larissa Akeme NakanoEduardo Luiz Rachid CançadoCleuber Esteves ChavesMaria Cristina Vaz MadeiraJéssica Toshie KatayoseMariana Akemi NabeshimaVictor FossaluzaGabriela Guimarães UhrigshardtZheng LitingVanusa Barbosa PintoFlair José CarrilhoSuzane Kioko Ono

Published in: BMC gastroenterology (2020)

ClinicalTrials.gov: NCT03489889 retrospectively registered on January 12th, 2018; Ethics Committee approved the study (ID: 1.790.088) on October 25th, 2016.

Keyphrases

public health
clinical trial
study protocol
phase iii
big data
phase ii
machine learning
artificial intelligence
placebo controlled
deep learning